Table 1.
Demographical and clinical characteristics of no-SCD versus SCD groups
| No-SCD (n = 104) | SCD (n = 84) | p-value | |
|---|---|---|---|
| Age | 37.3 ± 9.8 | 39.1 ± 10.0 | 0.228 |
| Sex (male/female) | 24/80 | 24/60 | 0.390 |
| Episodic/chronic headache | 84/20 | 65/19 | 0.569 |
| Migraine types (with aura/without aura/chronic/probable) | 5/75/20/4 | 8/58/18/0 | 0.179 |
| Frequency of attacks per month | 8.9 ± 8.1 | 10.2 ± 7.2 | 0.236 |
| Maximum pain duration in hours | 35.3 ± 54.0 | 31.3 ± 31.3 | 0.542 |
| Number of tablets per month | 4.3 ± 5.9 | 5.6 ± 6.7 | 0.169 |
| Pain intensity on VAS | 6.6 ± 1.8 | 7.2 ± 1.5 | 0.024 |
| HIT-6 | 59.2 ± 7.6 | 62.3 ± 7.0 | 0.005 |
| K-MMSE | 29.0 ± 1.5 | 28.9 ± 1.6 | 0.566 |
| K-MoCA | 27.5 ± 1.9 | 27.5 ± 2.0 | 0.966 |
VAS Visual Analogue Scale, HIT-6 Headache Impact Test-6, SCD subjective cognitive decline, K-MMSE Korean-Mini Mental State Examination, K-MoCA Korean-Montreal Cognitive Assessment